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1. INTRODUCTION {#jch13643-sec-0001}
===============

1.1. Background {#jch13643-sec-0002}
---------------

Hypertension is the leading risk factor for death[1](#jch13643-bib-0001){ref-type="ref"} with 12.8% of annual global mortality attributable to hypertension.[2](#jch13643-bib-0002){ref-type="ref"} More than 40 years ago, it was recognized that patients commonly had elevated blood pressure in hospital, but that follow‐up to determine whether they remained hypertensive in the community was poor.[3](#jch13643-bib-0003){ref-type="ref"}, [4](#jch13643-bib-0004){ref-type="ref"} More recent research suggests that recognition of elevated blood pressure (BP) among patients in hospital continues to be lacking[5](#jch13643-bib-0005){ref-type="ref"} and referral for community follow‐up remains poor.[6](#jch13643-bib-0006){ref-type="ref"}, [7](#jch13643-bib-0007){ref-type="ref"}, [8](#jch13643-bib-0008){ref-type="ref"}, [9](#jch13643-bib-0009){ref-type="ref"} One reason for this may be the absence of a definition for elevated inhospital BP in the literature and hypertension guidelines. Furthermore, physician perception that elevated inhospital BP is attributable to anxiety,[10](#jch13643-bib-0010){ref-type="ref"} pain,[11](#jch13643-bib-0011){ref-type="ref"} or white coat syndrome[12](#jch13643-bib-0012){ref-type="ref"} may underlie an expectation that elevated BP will normalize following discharge. However, these patients frequently remain hypertensive in the community,[13](#jch13643-bib-0013){ref-type="ref"}, [14](#jch13643-bib-0014){ref-type="ref"}, [15](#jch13643-bib-0015){ref-type="ref"}, [16](#jch13643-bib-0016){ref-type="ref"}, [17](#jch13643-bib-0017){ref-type="ref"}, [18](#jch13643-bib-0018){ref-type="ref"} including when the observed elevated BP occurs in emergency department (ED) triage.[19](#jch13643-bib-0019){ref-type="ref"}

1.2. Importance {#jch13643-sec-0003}
---------------

Untreated hypertension is associated with a progressive increase in BP that can become treatment‐resistant.[20](#jch13643-bib-0020){ref-type="ref"} Therefore, the hospital setting, in which BP is routinely measured, offers an opportunity for diagnostic screening to address this major cause of morbidity and mortality.[21](#jch13643-bib-0021){ref-type="ref"} Presently, however, guidance on the management of elevated BP in hospital is confined to the ED setting,[22](#jch13643-bib-0022){ref-type="ref"} and there is apparent lack of consensus on management and follow‐up of elevated BP for the inpatient setting. Even in the ED setting, the guidelines draw upon evidence from a limited number of studies which have major limitations such as small or unrepresentative cohorts and the authors of these guidelines recommend further research investigating optimal screening and follow‐up interval.

1.3. Goals of this investigation {#jch13643-sec-0004}
--------------------------------

This systematic review investigates the extent to which elevated inhospital BP measurements can predict the presence of hypertension in adults with no prior hypertensive diagnosis or treatment. The review presents the evidence to date to help inform clinical management of newly detected elevated BP in the hospital setting.

2. METHODS {#jch13643-sec-0005}
==========

The review is reported according to the Preferred Reporting Items for Systematic Review and Meta‐Analysis‐Diagnostic Test Accuracy (PRISMA‐DTA) statement.[23](#jch13643-bib-0023){ref-type="ref"} The protocol for this systematic review was prospectively registered on the International Prospective Register of Systematic Reviews (PROSPERO: registration number: CRD42018095400).

2.1. Eligibility criteria {#jch13643-sec-0006}
-------------------------

Studies relevant to this review were cohort studies in which hospital patients identified with BP exceeding study threshold were followed up post‐discharge for further BP assessment. Eligibility criteria for the participant cohort were as follows: Age ≥18 yearsNo pre‐existing diagnosis of hypertensionAttended ED or admitted to hospitalReason for index admission not being one of hypertension or hypertension‐Related end‐organ disease (eg, acute coronary syndrome, acute vascular injury, stroke, or end‐stage renal failure)No BP treatment initiated prior to follow‐up BP assessmentStratified for post‐discharge BP assessment using inhospital BP measurementsNot pregnant

For inclusion criterion "(ii)," studies were eligible if they included a statement that patients with a history of hypertension and prescribed antihypertensives were excluded. We did not specify the method of exclusion. For inclusion criterion "(v)," studies where all participants were commenced on antihypertensive medications prior to, upon discharge or between discharge and blood pressure follow‐up, were excluded. For studies where some, but not all, participants were started on antihypertensive medications at one of these points, those participants who remained without an antihypertensive prescription at blood pressure follow‐up were included in the meta‐analysis.

2.2. Search strategy {#jch13643-sec-0007}
--------------------

MEDLINE, EMBASE, and CINAHL databases were searched from inception to May 2018 for cohort studies meeting the above criteria. Search strategies were developed with a medical librarian. We used key terms relating to hospital patients (emergency department, inpatient, hospitalized), follow‐up (outpatient, home monitor, community), and BP measurements (blood pressure, ambulatory blood pressure monitoring). Where keywords revealed medical subject headings (MeSH) or index terms respective of database, these were included. Reference lists of identified articles were searched for additional titles. Results were limited to studies of adult populations and published journal articles. Studies published in all languages were eligible. Full search strategies are provided in Appendix [S1](#jch13643-sup-0001){ref-type="supplementary-material"}.

2.3. Study selection {#jch13643-sec-0008}
--------------------

Two reviewers (LA and MW) independently screened all citations by title and abstract. Any queries or disagreements were adjudicated with a third reviewer (AF). The same reviewers independently screened the full text of selected studies and again any disagreements resolved with the third reviewer. Reference lists of all included full‐text articles were screened by the first author (LA) and full text of relevant citations was screened independently by LA and MW for eligibility.

2.4. Data extraction {#jch13643-sec-0009}
--------------------

A custom data extraction form was piloted with one included study, by two reviewers (LA and MW). Data extraction for the remaining studies was then completed independently by both reviewers and compared for consistency. Any disagreements were resolved with a third reviewer (AF). Authors were contacted for information required but not available in published articles. Study characteristics included country, study design, participant characteristics, and sample size. Data related to the index and follow‐up BP assessment included sphygmomanometer type, BP threshold for the index and follow‐up assessments, follow‐up interval, and setting.

The following outcome data were extracted for each study: Number of patients in each cohort study eligible for inclusion in this review, defined as number of patients in the cohort who (i) had no prior diagnosis of hypertension and (ii) were not prescribed antihypertensive medication prior to follow‐up.Number of patients for whom follow‐up BP data were available.Number of those diagnosed with hypertension at follow‐upNumber of those with hypertension at follow‐up who commenced treatment.

The percentage diagnosed with hypertension at follow‐up was calculated on a per‐protocol basis from items 2 and 3. The pooled value for the proportion of individuals subsequently identified with hypertension at a common index threshold of 140/90 mm Hg was calculated using a random effects model in Stata (Version 11.2). Confidence intervals and overall effect size were calculated using the "metaprop" command. Heterogeneity was estimated using the I^2^ statistic (range: 0%‐100%). We investigated for trends in percentage of patients with hypertension at follow‐up against index BP threshold, BP data against which the index threshold was applied and method of follow‐up BP assessment.

2.5. Risk of bias assessment in individual studies {#jch13643-sec-0010}
--------------------------------------------------

Two reviewers (LA and MW) independently assessed the quality of manuscripts using approaches recommended in the Newcastle‐Ottawa Scale assessment tool.[24](#jch13643-bib-0024){ref-type="ref"} The main criteria were as follows: (a) representativeness of cohort; (b) ascertainment of \"exposure\" (elevated inhospital BP); (c) independent or blind assessment of outcome; (d) demonstration that the outcome of interest (hypertension diagnosis) was not present at study start; (e) suitable follow‐up period; and (f) adequacy of follow‐up. According to our predefined inclusion criteria, studies were eligible if they made an explicit statement that patients were screened to ensure the outcome of interest (diagnosis of hypertension) was not present at the start of the study. We did not assess the accuracy of screening for pre‐existing hypertension as part of the risk of bias assessment; this would not be possible without knowledge of specific study audit practice. None of the 12 included studies had a \"non‐exposed\" comparator group and so were not assessed against comparability items of the Newcastle‐Ottawa Scale. Further details outlining the method of assessing risk of bias are provided in Appendix [S2](#jch13643-sup-0001){ref-type="supplementary-material"}. Publication bias could not be assessed owing to lack of comparator groups in the included studies.

3. RESULTS {#jch13643-sec-0011}
==========

The initial electronic database search returned 4923 citations. A further 2 studies were identified from reference lists of identified articles (Figure [1](#jch13643-fig-0001){ref-type="fig"}). After removal of duplicates, 3993 citations were screened by title and abstract. Full texts of 43 (1.1%) articles considered potentially eligible were reviewed. Of these, 12 (27.9%) citations met inclusion criteria. Reasons for exclusion are presented; notably, a single study was excluded as only 1/146 study participants met eligibility criteria for this review.[25](#jch13643-bib-0025){ref-type="ref"} Across the 12 included studies, 2627 participants met eligibility criteria for this review. Follow‐up BP data were available for 1239 (47.2%) participants.

![The PRISMA flowchart of the study selection](JCH-21-1415-g001){#jch13643-fig-0001}

Study characteristics are presented in Table [1](#jch13643-tbl-0001){ref-type="table"}. The lowest mean age of a patient cohort was 43.9 years,[26](#jch13643-bib-0026){ref-type="ref"} and highest mean age was 60.1 years.[27](#jch13643-bib-0027){ref-type="ref"} Mean age was neither reported nor available from authors for 3 studies.[10](#jch13643-bib-0010){ref-type="ref"}, [28](#jch13643-bib-0028){ref-type="ref"}, [29](#jch13643-bib-0029){ref-type="ref"} In all studies, identification of eligible patients and study recruitment took place in the ED; no studies recruited patients from an inpatient setting.

###### 

Study characteristics

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors, year             Country       Study design                  Participant characteristics at recruitment   Eligibility BP threshold (mm Hg)   Eligible cohort sample size   Number with follow‐up data                                          
  ------------------------- ------------- ----------------------------- -------------------------------------------- ---------------------------------- ----------------------------- -------------------------------- --------------------------- ------ ------
  Chernow et al, 1987       USA           Prospective cohort            49                                           White                              81                            52.3                             \>159 systolic or\          68     68
                                                                                                                                                                                                                       \>94 diastolic                     

  Hispanic                  17                                                                                                                                                                                                                            

  Black                     1                                                                                                                                                                                                                             

  Other                     1                                                                                                                                                                                                                             

  Slater et al, 1987        UK            Prospective cohort            n/a                                          n/a                                n/a                           Single diastolic reading \>95    60                          53     

  Backer et al, 2003        USA           Prospective cohort            47                                           n/a                                53.6                          ≥140 systolic or\                405                         266    
                                                                                                                                                                                      ≥90 diastolic                                                       

  Dieterle et al, 2004      Switzerland   Prospective cohort            60.1 (19.9)                                  n/a                                68.3                          ≥160 systolic and\               45                          41     
                                                                                                                                                                                      ≥100 diastolic                                                      

  Fleming et al, 2005       UK            Prospective                   n/a                                          n/a                                54.9                          ≥140 systolic or\                126                         51     
                                                                                                                                                                                      ≥90 diastolic                                                       

  Karras et al, 2005        USA           Prospective cross‐sectional   51.9                                         White                              11.3                          53.7                             ≥140 systolic or\           346    49
                                                                                                                                                                                                                       ≥90 diastolic                      

  Hispanic                  21.7                                                                                                                                                                                                                          

  Black                     63.1                                                                                                                                                                                                                          

  Other                     2.6                                                                                                                                                                                                                           

  Tanabe et al, 2008        USA           Prospective cohort            n/a[a](#jch13643-note-0003){ref-type="fn"}   White                              62.2                          48.1                             ≥140 systolic or\           189    156
                                                                                                                                                                                                                       ≥90 diastolic                      

  Black                     33.3                                                                                                                                                                                                                          

  Asian                     1.2                                                                                                                                                                                                                           

  Other                     3.1                                                                                                                                                                                                                           

  Svenson et al, 2008       USA           Prospective cohort            n/a                                          n/a                                n/a                           ≥140 systolic or\                405                         39     
                                                                                                                                                                                      ≥90 diastolic                                                       

  Julliard et al, 2012      USA           Prospective cohort            43.9                                         n/a                                67.2                          Stage 1 HTN \>140 systolic or\   197                         17     
                                                                                                                                                                                      ≥90 diastolic\                                                      
                                                                                                                                                                                      or Stage 2 HTN\                                                     
                                                                                                                                                                                      ≥160 systolic or\                                                   
                                                                                                                                                                                      ≥100 diastolic                                                      

  Tsoi et al, 2012          Hong Kong     Prospective cross‐sectional   52\                                          Chinese                            100                           56.6                             systolic \>140 and \<180\   245    136
                                                                        (15)                                                                                                                                           or\                                
                                                                                                                                                                                                                       diastolic \>90 and \<120           

  Dolatabadi et al, 2014    Iran          Prospective cross‐sectional   46.7 (12.4)                                  n/a                                65.9                          ≥140 systolic or\                346                         168    
                                                                                                                                                                                      ≥90 diastolic                                                       

  Shiber‐Ofer et al, 2015   Israel        Prospective cohort            49.7(12.7)                                   n/a                                52.3                          ≥140 systolic or\                195                         195    
                                                                                                                                                                                      ≥90 diastolic                                                       

                                                                                                                                                                                                                       TOTAL                       2627   1239
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: BP, blood pressure; n/a, data not available; SD, standard deviation; UK, United Kingdom; USA, United States of America.

Unknown for whole cohort. Mean age for those with normal and high blood pressure at follow‐up was 44 and 51 y, respectively. All figures given to 1 decimal place where available.

John Wiley & Sons, Ltd

Of the 12 included studies, 6 were conducted in the United States, 2 in the United Kingdom, and 1 in each of Switzerland, Hong Kong, Israel, and Iran. Three studies reported data on ethnicity,[10](#jch13643-bib-0010){ref-type="ref"}, [30](#jch13643-bib-0030){ref-type="ref"}, [31](#jch13643-bib-0031){ref-type="ref"} and authors of 1 study provided data on ethnicity.[32](#jch13643-bib-0032){ref-type="ref"}

3.1. Risk of bias {#jch13643-sec-0012}
-----------------

The risk of bias assessment for all studies is demonstrated in Table [2](#jch13643-tbl-0002){ref-type="table"}. Cohorts in eleven of the 12 studies were deemed truly representative of the average in the community; one study excluded patients with an arm circumference \<19 cm or \>45 cm and was therefore considered somewhat representative.[33](#jch13643-bib-0033){ref-type="ref"} Overall, 3 studies were considered at low risk of bias,[10](#jch13643-bib-0010){ref-type="ref"}, [34](#jch13643-bib-0034){ref-type="ref"}, [35](#jch13643-bib-0035){ref-type="ref"} 1 at intermediate risk of bias,[27](#jch13643-bib-0027){ref-type="ref"} and 8 at high risk of bias.[19](#jch13643-bib-0019){ref-type="ref"}, [26](#jch13643-bib-0026){ref-type="ref"}, [28](#jch13643-bib-0028){ref-type="ref"}, [29](#jch13643-bib-0029){ref-type="ref"}, [30](#jch13643-bib-0030){ref-type="ref"}, [31](#jch13643-bib-0031){ref-type="ref"}, [32](#jch13643-bib-0032){ref-type="ref"}, [33](#jch13643-bib-0033){ref-type="ref"} One study screened patients for a pre‐existing diagnosis of hypertension through review of medical records, blood pressure measurements of previous hospital attendance, and prescription records[34](#jch13643-bib-0034){ref-type="ref"}; 4 studies screened through a review of notes and patient self‐report[11](#jch13643-bib-0011){ref-type="ref"}, [19](#jch13643-bib-0019){ref-type="ref"}, [30](#jch13643-bib-0030){ref-type="ref"}, [31](#jch13643-bib-0031){ref-type="ref"}; 2 studies screened through review of medical records only[27](#jch13643-bib-0027){ref-type="ref"}, [28](#jch13643-bib-0028){ref-type="ref"}; 1 study screened through patient self‐report only[33](#jch13643-bib-0033){ref-type="ref"}; and 4 studies did not report how patients were screened for a pre‐existing diagnosis of, or medication prescription for, hypertension.[26](#jch13643-bib-0026){ref-type="ref"}, [32](#jch13643-bib-0032){ref-type="ref"}, [35](#jch13643-bib-0035){ref-type="ref"}, [36](#jch13643-bib-0036){ref-type="ref"}

###### 

Quality assessment

  Author, year              Representativeness of cohort   Ascertainment of \"exposure\"   Demonstration that outcome of interest not present at start   Independent assessment of outcome   Suitable follow‐up period   Adequacy of cohort follow‐up   Conclusions
  ------------------------- ------------------------------ ------------------------------- ------------------------------------------------------------- ----------------------------------- --------------------------- ------------------------------ --------------
  Chernow et al, 1987                                                                                                                                                                                                                                   High
  Slater et al, 1987                                                                                                                                                                         n/a                                                        Intermediate
  Backer et al, 2003                                                                                                                                                                                                                                    High
  Dieterle et al, 2004                                                                                                                                                                                                                                  Low
  Fleming et al, 2005                                                                                                                                                                                                                                   High
  Karras et al, 2005                                                                                                                                                                                                                                    High
  Tanabe et al, 2008                                                                                                                                                                                                                                    Low
  Svenson et al, 2008                                                                                                                                                                                                                                   High
  Julliard et al, 2012                                                                                                                                                                                                                                  High
  Tsoi et al, 2012                                                                                                                                                                                                                                      High
  Dolatabadi et al, 2014                                                                                                                                                                                                                                High
  Shiber‐Ofer et al, 2015                                                                                                                                                                                                                               Low

n/a = data not available (assessment not possible).

John Wiley & Sons, Ltd

3.2. Blood pressure thresholds used for index and follow‐up assessment {#jch13643-sec-0013}
----------------------------------------------------------------------

Details of index and follow‐up BP assessments for each study are shown in Table [3](#jch13643-tbl-0003){ref-type="table"}. The location of index BP testing was the ED in all studies. The most common index BP threshold utilized was ≥140 mm Hg systolic or ≥90 mm Hg diastolic (also the lowest threshold).[10](#jch13643-bib-0010){ref-type="ref"}, [19](#jch13643-bib-0019){ref-type="ref"}, [26](#jch13643-bib-0026){ref-type="ref"}, [28](#jch13643-bib-0028){ref-type="ref"}, [29](#jch13643-bib-0029){ref-type="ref"}, [31](#jch13643-bib-0031){ref-type="ref"}, [32](#jch13643-bib-0032){ref-type="ref"}, [33](#jch13643-bib-0033){ref-type="ref"}, [34](#jch13643-bib-0034){ref-type="ref"} No studies were identified in which separate index BP thresholds were applied for night versus daytime. The method of index BP assessment varied between studies, from a single measurement,[31](#jch13643-bib-0031){ref-type="ref"} to half or more of all ED triage measurements required to exceed the index threshold.[26](#jch13643-bib-0026){ref-type="ref"} The most common method of BP assessment at follow‐up was clinician‐measured BP in either primary[26](#jch13643-bib-0026){ref-type="ref"}, [27](#jch13643-bib-0027){ref-type="ref"}, [31](#jch13643-bib-0031){ref-type="ref"}, [32](#jch13643-bib-0032){ref-type="ref"}, [34](#jch13643-bib-0034){ref-type="ref"}, [35](#jch13643-bib-0035){ref-type="ref"} or secondary[19](#jch13643-bib-0019){ref-type="ref"}, [28](#jch13643-bib-0028){ref-type="ref"}, [30](#jch13643-bib-0030){ref-type="ref"}, [33](#jch13643-bib-0033){ref-type="ref"} care clinics. One study used patient‐performed home BP monitoring.[10](#jch13643-bib-0010){ref-type="ref"} Two studies collected daytime ambulatory BP monitoring data where possible.[34](#jch13643-bib-0034){ref-type="ref"}, [35](#jch13643-bib-0035){ref-type="ref"}

###### 

Index test and reference standard tests

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors, year             Index test   Reference test                                                                                                                                                                                                                                                                                                                                 
  ------------------------- ------------ -------------------------------- ----------------------------------------------------------------------------- ----------------------------------------------- ----------------------- ------------------------------------------------------------------------------------------ ------------------------------------------------------------ -------------------------------------------------
  Chernow et al, 1987       Mercury      \>159 systolic or\               Triage and discharge measurements                                             ≤6 wk                                           n/a                     ≥140 systolic or \>90 diastolic                                                            Office BP                                                    Outpatient clinic (patient self‐report of this)
                                         \>94 diastolic                                                                                                                                                                                                                                                                                                                                 

  Slater et al, 1987        n/a          Single diastolic reading \>95    Single measurement                                                            n/a                                             n/a                     n/a                                                                                        Office BP                                                    Primary care

  Backer et al, 2003        Automated    ≥140 systolic or\                First measurement                                                             ≤6 mo                                           n/a                     ≥140 systolic or ≥90 diastolic                                                             Maximum of 2 office BP measurements                          Outpatient clinic
                                         ≥90 diastolic                                                                                                                                                                                                                                                                                                                                  

  Dieterle et al, 2004      Mercury      ≥165 systolic and\               Mean ABPM taken at 5‐min intervals between 60 and 80 min after entry to ED.   1 wk                                            Automated ABPM or n/a   ABPM: ≥135 systolic or ≥85 diastolic\                                                      12 h of ABPM at 20 min intervals\                            ABPM or primary care
                                         ≥105 diastolic                                                                                                                                                                         Office BP: ≥140 systolic or ≥90 diastolic                                                  or\                                                          
                                                                                                                                                                                                                                                                                                                           office BP in primary care                                    

  Fleming et al, 2005       Mercury      ≥140 systolic or\                Mean of 2 measurements taken 2 min apart                                      12.4 d (5‐23)                                   Mercury                 ≥140 systolic or ≥90 diastolic                                                             Last of 3 office BPs taken 2 min apart                       Non‐acute ED
                                         ≥90 diastolic                                                                                                                                                                                                                                                                                                                                  

  Karras et al, 2005        Variable     ≥140 systolic or\                Single measurement                                                            ≤3 wk                                           n/a                     n/a                                                                                        Office BP                                                    Primary care
                                         ≥90 diastolic                                                                                                                                                                                                                                                                                                                                  

  Tanabe et al, 2008        n/a          ≥140 systolic or\                2 consecutive measurements                                                    1 wk[^a^](#jch13643-note-0006){ref-type="fn"}   Automated               ≥140 systolic\                                                                             Mean home BP (after excluding highest and lowest readings)   HBPM: 2 measurements per day
                                         ≥90 diastolic                                                                                                                                                                          or\                                                                                                                                                     
                                                                                                                                                                                                                                ≥90 diastolic\                                                                                                                                          
                                                                                                                                                                                                                                (≥130 systolic\                                                                                                                                         
                                                                                                                                                                                                                                or\                                                                                                                                                     
                                                                                                                                                                                                                                ≥80 diastolic if DM)                                                                                                                                    

  Svenson et al, 2008       n/a          ≥140 systolic or\                Last recorded measurement                                                     ≤4 mo                                           n/a                     n/a                                                                                        Office BP                                                    Outpatient clinic
                                         ≥90 diastolic                                                                                                                                                                                                                                                                                                                                  

  Julliard et al, 2012      n/a          Stage 1 HTN \>140 systolic or\   Half or more of all (maximum 5) triage blood pressure measurements            ≤3 mo                                           n/a                     n/a, based on diagnostic code in medical record                                            Office BP                                                    Primary care
                                         ≥90 diastolic\                                                                                                                                                                                                                                                                                                                                 
                                         or Stage 2 HTN\                                                                                                                                                                                                                                                                                                                                
                                         ≥160 systolic or\                                                                                                                                                                                                                                                                                                                              
                                         ≥100 diastolic                                                                                                                                                                                                                                                                                                                                 

  Tsoi et al, 2012          n/a          systolic \>140 and \<180\        Triage and discharge measurements                                             ≤2 wk                                           n/a                     n/a                                                                                        Office BP                                                    Primary care
                                         or\                                                                                                                                                                                                                                                                                                                                            
                                         diastolic \>90 and \<120                                                                                                                                                                                                                                                                                                                       

  Dolatabadi et al, 2014    Mercury      ≥140 systolic or\                2 consecutive measurements taken 10 min apart                                 1 mo                                            Mercury                 ≥140 systolic\                                                                             Office BP                                                    Outpatient clinic
                                         ≥90 diastolic                                                                                                                                                                          or\                                                                                                                                                     
                                                                                                                                                                                                                                ≥90 diastolic                                                                                                                                           

  Shiber‐Ofer et al, 2015   Automated    ≥140 systolic or\                2 consecutive measurements taken 5 min apart                                  30.14 mo (±15.96)                               Automated ABPM or n/a   Office BP values\>/‐140/90, mean ABPM \>135/85 or antihypertensive medications commenced   ABPM or office BP                                            Primary care or outpatient clinic
                                         ≥90 diastolic                                                                                                                                                                                                                                                                                                                                  
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: ABPM, ambulatory blood pressure monitoring; BP, blood pressure; d, days; HBPM, home blood pressure monitoring; mo, months; n/a, data not available; wk, weeks.

Blood pressure was monitored at home for 1 wk.

John Wiley & Sons, Ltd

Post‐discharge follow‐up intervals ranged from 1 week[10](#jch13643-bib-0010){ref-type="ref"}, [35](#jch13643-bib-0035){ref-type="ref"} to 30.14 (±15.96) months.[34](#jch13643-bib-0034){ref-type="ref"} Median time to follow‐up was 1 month. Six studies (50%) reported the blood pressure follow‐up interval as the maximal time period to follow‐up among all participants.[19](#jch13643-bib-0019){ref-type="ref"}, [26](#jch13643-bib-0026){ref-type="ref"}, [28](#jch13643-bib-0028){ref-type="ref"}, [30](#jch13643-bib-0030){ref-type="ref"}, [31](#jch13643-bib-0031){ref-type="ref"}, [32](#jch13643-bib-0032){ref-type="ref"} Nine studies (75%) performed follow‐up by prospective review of patient notes (record linkage).[19](#jch13643-bib-0019){ref-type="ref"}, [26](#jch13643-bib-0026){ref-type="ref"}, [27](#jch13643-bib-0027){ref-type="ref"}, [28](#jch13643-bib-0028){ref-type="ref"}, [29](#jch13643-bib-0029){ref-type="ref"}, [33](#jch13643-bib-0033){ref-type="ref"}, [34](#jch13643-bib-0034){ref-type="ref"}, [35](#jch13643-bib-0035){ref-type="ref"} Three studies (25%) had notably low rates of available follow‐up BP data (\<20%).[26](#jch13643-bib-0026){ref-type="ref"}, [28](#jch13643-bib-0028){ref-type="ref"}, [31](#jch13643-bib-0031){ref-type="ref"}

3.3. Proportion of patients identified as hypertensive at follow‐up {#jch13643-sec-0014}
-------------------------------------------------------------------

The principal diagnostic accuracy measure reported by studies was the number of patients recorded as having elevated BP (as defined by the study\'s diagnostic threshold for hypertension) or a recorded diagnosis of hypertension at follow‐up. Outcome data for all studies are displayed in Table [4](#jch13643-tbl-0004){ref-type="table"}. The median percentage of patients identified as hypertensive at follow‐up was 43.6% (range: 14.2‐76.5). Across the 7 studies which used a common index BP threshold of 140/90, the pooled proportion of people identified with hypertension at follow‐up was 43.4% (95% CI: 25.1%‐61.8%; Figure [2](#jch13643-fig-0002){ref-type="fig"}). The I^2^ measure of heterogeneity between studies was high, at 97.3% (*P* \< .001).

###### 

Follow‐up outcome data

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year              Index blood pressure threshold   Eligible cohort number   Number (%) with available follow‐up blood pressure   Number (%) of those with elevated follow‐up BP   Percentage (n) commenced on treatment at follow‐up
  ------------------------- -------------------------------- ------------------------ ---------------------------------------------------- ------------------------------------------------ ----------------------------------------------------
  Chernow et al, 1987       \>159 systolic or\               68                       68 (100)                                             42 (62)                                          43 (18)[^a^](#jch13643-note-0008){ref-type="fn"}
                            \>94 diastolic                                                                                                                                                  

  Slater et al, 1987        Single diastolic reading \>95    60                       53 (88)                                              15 (28)                                          93.3 (14)

  Backer et al, 2003        ≥140 systolic or\                405                      266 (67)                                             66 (25)                                          n/a
                            ≥90 diastolic                                                                                                                                                   

  Dieterle et al, 2004      ≥165 systolic and\               45                       41 (91)                                              26 (63)                                          n/a
                            ≥105 diastolic                                                                                                                                                  

  Fleming et al, 2005       ≥140 systolic or\                126                      51 (40)                                              39 (76)                                          n/a
                            ≥90 diastolic                                                                                                                                                   

  Karras et al, 2005        ≥140 systolic or\                346                      49 (14)                                              7 (14)                                           n/a
                            ≥90 diastolic                                                                                                                                                   

  Tanabe et al, 2008        ≥140 systolic or\                189                      156 (83)                                             79 (51)                                          n/a
                            ≥90 diastolic                                                                                                                                                   

  Svenson et al, 2008       ≥140 systolic or\                405                      39 (10)                                              17 (44)                                          n/a
                            ≥90 diastolic                                                                                                                                                   

  Julliard et al, 2012      Stage 1 HTN \>140 systolic or\   197                      17 (9)                                               5 (29)                                           40 (2)
                            ≥90 diastolic\                                                                                                                                                  
                            or Stage 2 HTN\                                                                                                                                                 
                            ≥160 systolic or\                                                                                                                                               
                            ≥100 diastolic                                                                                                                                                  

  Tsoi et al, 2012          systolic \>140 and \<180\        245                      136 (56)                                             48 (35)                                          91.7 (44)
                            or\                                                                                                                                                             
                            diastolic \>90 and \<120                                                                                                                                        

  Dolatabadi et al, 2014    ≥140 systolic or\                346                      168 (49)                                             48 (29)                                          n/a[^b^](#jch13643-note-0009){ref-type="fn"}
                            ≥90 diastolic                                                                                                                                                   

  Shiber‐Ofer et al, 2015   ≥140 systolic or\                195                      195 (100)                                            142 (73)                                         91.5 (130)
                            ≥90 diastolic                                                                                                                                                   
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: BP, blood pressure; HTN, hypertension; n/a, not applicable.

Article states all 48 participants identified as hypertensive at follow‐up were referred to an internist for treatment.

Treatment included either starting medication, dietary changes, or initiating a \"hypertension workup\".

John Wiley & Sons, Ltd

![Forest plot demonstrating the pooled proportion of people across the seven studies who were identified with possible hypertension at the index test using a detection threshold of 140/90 and who were subsequently identified with hypertension](JCH-21-1415-g002){#jch13643-fig-0002}

There were no trends in the proportion of participants identified as having hypertension at follow‐up when studies were compared on index BP threshold, BP data against which the threshold was applied, or method of outcome assessment (self‐report, record linkage, or independent BP assessment; see Table [S1‐S3](#jch13643-sup-0001){ref-type="supplementary-material"}). It was not possible to perform statistical analysis of outcome measure according to ethnicity, owing to small sample sizes and small number of studies reporting ethnicity. However, it was noted that the two studies in which the majority of the cohort were white, reported follow‐up hypertension rates of 50.6%[10](#jch13643-bib-0010){ref-type="ref"} and 62%[30](#jch13643-bib-0030){ref-type="ref"} and those studies in which the majority of the cohort were of a non‐white ethnic group reported lower follow‐up hypertension rates of 14.3%[31](#jch13643-bib-0031){ref-type="ref"} and 35.3%.[32](#jch13643-bib-0032){ref-type="ref"}

4. DISCUSSION {#jch13643-sec-0015}
=============

4.1. Summary of evidence {#jch13643-sec-0016}
------------------------

This review of diagnostic studies aimed to evaluate the extent to which elevated inhospital BP measurements can predict the presence of undiagnosed hypertension. We identified twelve studies which investigated this question within the emergency department population, but none in the inpatient population. The lowest index BP threshold identified among these studies was 140 mm Hg systolic or 90 mm Hg diastolic. All studies identified a proportion of patients with hypertension at follow‐up; excluding studies with \<20% follow‐up, post‐discharge diagnosis of hypertension occurred in around 25% or more participants. Among studies assessed as being at low risk of bias, post‐discharge diagnosis of hypertension occurred in over 50% of participants (range: 50.6%[7](#jch13643-bib-0007){ref-type="ref"}‐72.3%[34](#jch13643-bib-0034){ref-type="ref"}). This consistent identification of undiagnosed hypertensive patients demonstrates the potential clinical benefit of utilizing hospital attendance to screen for undiagnosed hypertension.

Despite consistent identification of people with hypertension among the included studies, there was marked variability in reported prevalence between studies (range: 14.3%‐76.5%; 24.8%‐76.5% when low follow‐up rate studies are excluded). Variability could not be accounted for by index BP threshold, BP measurements against which index thresholds were applied, or method of follow‐up BP assessment (Tables [S1‐S3](#jch13643-sup-0001){ref-type="supplementary-material"}). It is possible this variability is attributable to heterogeneity between studies including cohort demographics and methodology (eg, index and follow‐up BP assessments, and follow‐up interval).

All studies performed index BP assessments in the ED, with no studies utilizing inpatient hospital data. This may, in part, explain the lack of guidance on the management of inpatient hypertension. Of the 12 studies, 11 used routinely collected BP measurements from ED to identify potential participants.[7](#jch13643-bib-0007){ref-type="ref"}, [19](#jch13643-bib-0019){ref-type="ref"}, [26](#jch13643-bib-0026){ref-type="ref"}, [27](#jch13643-bib-0027){ref-type="ref"}, [28](#jch13643-bib-0028){ref-type="ref"}, [30](#jch13643-bib-0030){ref-type="ref"}, [31](#jch13643-bib-0031){ref-type="ref"}, [32](#jch13643-bib-0032){ref-type="ref"}, [33](#jch13643-bib-0033){ref-type="ref"}, [35](#jch13643-bib-0035){ref-type="ref"} Six used these measurements for the index BP assessment,[19](#jch13643-bib-0019){ref-type="ref"}, [26](#jch13643-bib-0026){ref-type="ref"}, [27](#jch13643-bib-0027){ref-type="ref"}, [28](#jch13643-bib-0028){ref-type="ref"}, [31](#jch13643-bib-0031){ref-type="ref"}, [32](#jch13643-bib-0032){ref-type="ref"} while five reassessed BP through additional measurements in ED.[7](#jch13643-bib-0007){ref-type="ref"}, [30](#jch13643-bib-0030){ref-type="ref"}, [33](#jch13643-bib-0033){ref-type="ref"}, [34](#jch13643-bib-0034){ref-type="ref"}, [35](#jch13643-bib-0035){ref-type="ref"} One study did not use routinely collected BP for screening and performed BP screening measurements independent of usual observations made in ED.[29](#jch13643-bib-0029){ref-type="ref"}

Most studies used international thresholds (≥140 mm Hg systolic or ≥90 mm Hg diastolic) to diagnose hypertension at follow‐up. However, follow‐up methodology varied by setting (home, ambulatory, or office), method of BP data collection (record linkage, participant self‐report, measured by research personnel), and follow‐up interval. While recent American guidelines for hypertension present values of equivalence according to setting, the varying methods of BP follow‐up seen in the included studies mean some caution are required in comparing proportions of patients subsequently diagnosed with hypertension between these studies.

It has been reported previously that referral for follow‐up assessment of patients identified with elevated inhospital BP is lacking.[21](#jch13643-bib-0021){ref-type="ref"} Underlying reasons may include physician perceptions regarding causes of elevated inhospital BP[11](#jch13643-bib-0011){ref-type="ref"} and the lack of evidence on further management of elevated inhospital BP in the nonemergency setting.[20](#jch13643-bib-0020){ref-type="ref"}, [37](#jch13643-bib-0037){ref-type="ref"}, [38](#jch13643-bib-0038){ref-type="ref"} Our review highlights the need for research to be undertaken on patients with inhospital hypertension.

4.2. Strengths and limitations at study and outcome level {#jch13643-sec-0017}
---------------------------------------------------------

This review of diagnostic studies is limited by studies either not collecting or reporting data which could be used to calculate sensitivity and specificity for index BP thresholds. In addition, interpretation of the pooled analysis of proportions among the 7 studies sharing a common index BP threshold is necessarily cautious due to heterogeneity between these studies. Some of this heterogeneity will result from fundamental differences in study design between the included studies. Therefore, questions remain regarding the appropriately sensitive and specific inhospital BP thresholds against which patients may be screened for undiagnosed hypertension. Additional high‐quality research is needed in this field to establish the optimal methodology for index BP assessment, including index BP threshold.

Differences between reference standard tests for hypertension between the studies also limit the comparability of results, and most studies did not use ambulatory blood pressure monitoring for the reference standard. Though this may be considered the gold standard method, recently published guidelines and the wider literature appear to be steering away from the requirement of ambulatory monitoring for a diagnosis of hypertension.[37](#jch13643-bib-0037){ref-type="ref"}, [39](#jch13643-bib-0039){ref-type="ref"} However, the methods of blood pressure measurement seen in the included studies may reflect \"real world\" rather than \"gold standard\" practice. As a result, interpretations of these results may still be meaningful in normal clinical practice.

4.3. Strengths and limitations at review level {#jch13643-sec-0018}
----------------------------------------------

This review was conducted according to the registered PROSPERO protocol.[40](#jch13643-bib-0040){ref-type="ref"} Studies of all languages were eligible, and included studies were conducted in a variety of countries. Databases were searched from inception, adding to the comprehensive nature of the review; publication dates ranged from 1987 to 2016. However, inclusion of older studies meant authors could not be contacted to obtain older data or that data had sometimes been destroyed. Risk of bias was assessed using a well‐established tool for cohort studies; however, the applicability of a formal assessment of bias in the context of single‐group observational studies is limited.

The high degree of heterogeneity between studies means our estimate of the overall incidence of community hypertension following raised emergency department readings should be interpreted cautiously. Meta‐regression or subgroup analysis for sources of heterogeneity would not have been appropriate owing to small number of studies and all studies differing from each other on more than one point of methodology. However, all studies showed a substantial incidence of hypertension in the community once it had been identified in the emergency department setting.

5. CONCLUSIONS {#jch13643-sec-0019}
==============

This review of 12 studies has demonstrated that hypertension screening in the acute hospital setting consistently identifies groups of patients with undiagnosed hypertension. Unscheduled hospital attendance therefore offers an important public health opportunity to identify patients with undiagnosed hypertension and has potential to reduce patient burden attributed to the major morbidities and mortality associated with hypertension. However, we were unable to identify any studies of hospital inpatients and found notable differences in reported rates of hypertension at follow‐up, likely due to marked variation in methodology. This highlights the need for further research involving hospital inpatients and a consistent and systematic methodology for screening and follow‐up assessment.
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